ALKERMES | Capitalisation Boursière

Market Capitalization Changement Date
AbbVie USD 273.6B 10.51B 2023-12
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
Acorda Therapeutics USD 16M 2M 2023-06
ALKERMES USD 4.63B 36M 2023-12
Amgen USD 154.14B 10.38B 2023-12
Biogen USD 37.5B 274M 2023-12
BioMarin Pharmaceutical USD 18.16B 1.51B 2023-12
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Gilead Sciences USD 100.94B 7.57B 2023-12
Heron Therapeutics USD 145M 6M 2023-09
Intra Cellular Therapies USD 6.67B 227M 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Malin Corporation EUR 88.78M 158.03M 2023-06
Marinus Pharmaceuticals USD 407M 142M 2023-09
Merck USD 314.33B 38.07B 2024-03
Minerva Neurosciences USD 43M 5M 2023-12
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Otsuka Holdings JPY 2.95T 14.58B 2023-12
Ovoca Bio GBP 7.54M 4.28M 2022-06
Pfizer USD 155.51B 7.05B 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Revance Therapeutics USD 772M 237M 2023-12
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



ALKERMES Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.